Monoaminergic impairment in Down syndrome with Alzheimer's disease compared to early‐onset Alzheimer's disease

Abstract Introduction People with Down syndrome (DS) are at high risk for Alzheimer's disease (AD). Defects in monoamine neurotransmitter systems are implicated in DS and AD but have not been comprehensively studied in DS. Methods Noradrenaline, adrenaline, and their metabolite 3‐methoxy‐4‐hydr...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Alain D. Dekker, Yannick Vermeiren, Maria Carmona‐Iragui, Bessy Benejam, Laura Videla, Ellen Gelpi, Tony Aerts, Debby Van Dam, Susana Fernández, Alberto Lleó, Sebastian Videla, Anne Sieben, Jean‐Jacques Martin, Netherlands Brain Bank, Rafael Blesa, Juan Fortea, Peter P. De Deyn
格式: Artigo
語言:Inglês
出版: Wiley 2018-01-01
叢編:Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
主題:
Alzheimer's disease
Cerebrospinal fluid
Dementia
Dopamine
Down syndrome
Monoamines
在線閱讀:https://doi.org/10.1016/j.dadm.2017.11.001
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍